BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14619449)

  • 1. [Recent progress in the protein-tyrosine phosphatase SHP1 gene: the significant correlation of the SHP1 gene silencing with the onset of lymphomas/leukemias].
    Oka T; Ouchida M
    Nihon Rinsho; 2003 Nov; 61(11):2025-32. PubMed ID: 14619449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
    Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
    Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
    Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
    Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
    Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
    Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
    Koyama M; Oka T; Ouchida M; Nakatani Y; Nishiuchi R; Yoshino T; Hayashi K; Akagi T; Seino Y
    Lab Invest; 2003 Dec; 83(12):1849-58. PubMed ID: 14691303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.
    Shivapurkar N; Takahashi T; Reddy J; Zheng Y; Stastny V; Collins R; Toyooka S; Suzuki M; Parikh G; Asplund S; Kroft SH; Timmons C; McKenna RW; Feng Z; Gazdar AF
    Cancer Res; 2004 Jun; 64(11):3757-60. PubMed ID: 15172980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
    Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
    Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter.
    Ying J; Li H; Cui Y; Wong AH; Langford C; Tao Q
    Leukemia; 2006 Jun; 20(6):1173-5. PubMed ID: 16572203
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas.
    Go JH
    Mod Pathol; 2003 Aug; 16(8):752-5. PubMed ID: 12920218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
    Hayslip J; Montero A
    Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
    Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
    Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic analysis of hematopoietic neoplasms].
    Ogawa S
    Nihon Rinsho; 2005 Mar; 63(3):506-13. PubMed ID: 15773353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells.
    Bittorf T; Seiler J; Zhang Z; Jaster R; Brock J
    Biol Chem; 1999 Oct; 380(10):1201-9. PubMed ID: 10595583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
    Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
    Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
    J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.